JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KADOWITZ, P. J.
Right arrow Articles by BRODY, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KADOWITZ, P. J.
Right arrow Articles by BRODY, M. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 177, Issue 3, 641-649, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


DIFFERENTIAL EFFECTS OF PROSTAGLANDINS E1, E2, F1agr AND F2agr ON ADRENERGIC VASOCONSTRICTION IN THE DOG HINDPAW

PHILIP J. KADOWITZ 1, CHARLES S. SWEET 1, and MICHAEL J. BRODY 1

1 Department of Pharmacology, College of Medicine, University of Iowa, Iowa City, Iowa

The influence of i.a. infusions of equivalent doses of prostaglandins (PG) E1, E2, F1agr and F2agr on vasoconstrictor responses to norepinephrine and sympathetic nerve stimulation were evaluated in the dog hindpaw perfused at constant flow. Infusions of PGE1 and PGE2,1 µg/min, decreased vascular resistance in the hindpaw. PGE1 markedly reduced responses to i.a. norepinephrine, angiotensin and sympathetic nerve stimulation whereas PGE2 did not alter these responses. However, when the infusion rate was increased to 2 µg/min, responses to nerve stimulation, but not norepinephrine, were enhanced. Infusion of PGF1agr, and PGF2agr, 1 µg/min, caused no change in vancular resistance in the hindpaw but enhanced the response to sympathetic nerve stimulation. PGF1agr, decreased the response to norepinephrine whereas PGF2agr, was without effect. These results suggest that PGF2agr may enhance adrenergic transmission in the hindpaw by facilitating the release of transmitter from sympathetic nerve endings and that PGE1 may decrease the sensitivity of the cutaneous vessels to norepinephrine by a nonspecific effect. These data provide further support for the postulate that, by a variety of mechanisms, prostaglandins may serve as modulators of adrenergic responses in vascular smooth muscle.

Submitted on October 28, 1970
Accepted on February 17, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.